AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Onconetix, Inc. Director's Dealing 2024

Jan 3, 2024

35411_dirs_2024-01-03_7e927d66-d76e-4e74-b32d-4803b0bc3d15.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Onconetix, Inc. (ONCO)
CIK: 0001782107
Period of Report: 2023-12-15

Reporting Person: Schiess Ralph (Chief Science Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	269749	Direct